Early Alzheimer’s Disease
Have you or a loved one been diagnosed with Early Alzheimer’s?
Learn more about a research study examining a drug that may help slow Alzheimer’s disease progression.
To qualify, you must:
- Be 55-90 years old
- Have symptoms in the early stages of AD include difficulties with memory, planning, and organization. Many people in these stages also find it challenging to learn new information, follow directions, and come up with the right words to describe something. Nonetheless, most can still function independently in daily life.
Qualified participants will receive:
- Study-related medication at no cost
- Study-related medical exams at no cost
- Compensation for time and travel
Contribute to the advancement of medical knowledge and treatments, while receiving expert medical care under close supervision.
The M3 Wake Research Network has powered innovation with over 9,100 Successful Clinical Trials in patients from 6 months to 85 years.
Patient safety is paramount with strict protocols and ethical guidelines, minimizing risks and ensuring thorough monitoring throughout the trial.